InfuSystem Holdings (INFU) EPS (Weighted Average and Diluted) (2010 - 2026)
InfuSystem Holdings (INFU) reported EPS (Weighted Average and Diluted) of $0.05 for Q1 2026, up 600.0% on a YoY basis from $0.01 in Q1 2025, and down 44.44% quarter-over-quarter from $0.09 in Q4 2025.
InfuSystem Holdings (INFU) EPS (Weighted Average and Diluted) (2010 - 2026) Analysis & Trends
InfuSystem Holdings has reported EPS (Weighted Average and Diluted) for 17 years, with the latest figure at $0.05 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 600.0% year-over-year to $0.05; the trailing twelve-month figure through Mar 2026 stood at $0.37 (up 164.29% YoY), and the FY2025 full-year result was $0.31, up 181.82% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at $0.05, down from $0.09 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.12 in Q2 2025, with the low at -$0.05 in Q1 2024.
- Historically, EPS (Weighted Average and Diluted) has averaged $0.03 across 5 years, with a median of $0.02 in 2022.
- Annual changes were most pronounced in 2022 — EPS (Weighted Average and Diluted) tumbled 166.67% — and 2024, when it soared 1703.84%.
- InfuSystem Holdings' EPS (Weighted Average and Diluted) stood at $0.0 in 2022, then plunged by 55.34% to $0.0 in 2023, then soared by 1703.84% to $0.04 in 2024, then soared by 125.0% to $0.09 in 2025, then sank by 44.44% to $0.05 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at $0.05 (Q1 2026), $0.09 (Q4 2025), and $0.11 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | InfuSystem Holdings | 189.78 Mn | 187.68 Mn | 19.68 Mn | 0.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.05 |
| Dec 31, 2025 | 0.09 |
| Sep 30, 2025 | 0.11 |
| Jun 30, 2025 | 0.12 |
| Mar 31, 2025 | -0.01 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.08 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | -0.05 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | -0.01 |
| Mar 31, 2022 | -0.02 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | -0.02 |
| Jun 30, 2021 | 0.04 |